NEUROLOGICAL SIGN

Punding in Parkinson’s disease

Sean S O’Sullivan¹, Andrew H Evans³ and Andrew J Lees²

¹ Clinical Research Fellow
² Clinical Director, Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London, London, UK
³ Department of Neurology, Royal Melbourne Hospital, Parkville, Australia

Correspondence to:
Professor A J Lees, Reta Lila Weston Institute of Neurological Studies, UCL, 1 Wakefield Street, London WC1N 1PJ, UK; alees@ion.ucl.ac.uk

The first 150 words of the full text of this article appear below.

Punding is defined as a constellation of complex, sterile and stereotyped behaviours including an intense fascination with repetitive manipulations of technical equipment, the continual handling, examining, and sorting of common objects, excessive grooming, hoarding, incessant fidgeting at clothes or oneself, pointless driving or walkabouts, and the engagement in extended monologues devoid of rational content.¹ It was first described in amphetamine and cocaine addicts in 1972,² and the term comes from the Swedish slang for "block-head" used by amphetamine addicts to describe their repetitive and pointless activities.³ Since Friedman’s first description of punding in an L-dopa treated patient in 1994, there has been increased interest in this largely unrecognised behavioural disorder leading to appreciable morbidity in Parkinson’s disease.⁴ It has also been attributed to the use of dopamine agonists,⁵ and two cases of punding behaviours have been described after starting the antipsychotic quetiapine, although the patients were also on L-dopa.⁶

A . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Editor’s choice

Charles Warlow
Practical Neurology 2007 7: 353. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Evans, A H, Lawrence, A D, Lees, A J (2009). Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 80: 267-272 [Abstract] [Full Text]